Drug Toxicity Clinical Trial
Official title:
Laboratory Analysis of Toxic Agents in Suspected GHB Poisoning, Clinical Course and Predictors of Hospitalization in GHB Poisoning, and Laboratory Analysis of Toxic Agents in Poisoning Induced by Others
Patients with suspected GHB poisoning presenting to Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) or a hospital in Oslo (Oslo University Hospital Ullevål, Diakonhjemmet, Lovisenberg) will be included. Oral fluid and blood tests will be analyzed for recreational drugs. Clinical course will be charted, as well as treatment in the ambulance, emergency outpatient clinic and hospital to find predictors for when hospitalization is required. In the second part of the study the investigators will analyze urine and blood samples from patients presenting to the Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) with suspected substance poisoning induced by others, for toxic agents.
Gammahydroxybutyrate (GHB) causes severe poisoning that requires emergency medical and hospital care. In addition, it is used as an anesthetic for planned sexual assault. Laboratory analyses will help assess whether today's clinical diagnostics of GHB poisoning are precise enough, possibly being a supplement to improve it. Can GHB poisoned patients be treated safely by emergency medical services or do these patients need hospitalization? In case of substance poisoning induced by others, sampling could identify substances that are quickly excreted from the body. Today patients are referred to private laboratories the following day, delaying the diagnosis and missing short-term drugs. Method: Prospective study. Oral fluid and blood samples will be collected from patients over 16 years of age where there is a clinical suspicion of GHB poisoning on arrival at Oslo Accident and Emergency Outpasient Clinic (Oslo Legevakt) or hospital (OUH Ullevål, Lovisenberg and Diakonhjemmet). Blood and urine samples will be collected from patients over the age of 16 who present at the Oslo Accident and Emergency Outpasient clinic (Oslo Legevakt) with suspected substance poisoning induced by others. In both pasient groups the investigators will also register age, gender, clinically suspected toxic agents, vital signs, clinical features and treatment. The aims of this study are to see if the clinical diagnosis of GHB poisoning is precise enough, and whether more patients can be handled at an emergency outpatient level. Furthermore, analysis of blood and urine samples from patients who suspect they have been poisoned by substances induced by others, will be done to identify toxic agents. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03265613 -
Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04696081 -
Atrial Fibrillation in Active Cancer Patients
|
||
| Completed |
NCT04120233 -
MW151-101: First-in-human Study of MW151
|
Phase 1 | |
| Recruiting |
NCT01965275 -
High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs
|
Phase 2 | |
| Completed |
NCT01614080 -
Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA
|
N/A | |
| Recruiting |
NCT04659343 -
TDM for Optimized Outcome in Patients With mRCC.
|
||
| Completed |
NCT02864030 -
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
|
Phase 4 | |
| Completed |
NCT01135680 -
Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100
|
Phase 1 | |
| Completed |
NCT03947034 -
Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)
|
||
| Recruiting |
NCT03885388 -
Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6
|
Phase 2/Phase 3 | |
| Completed |
NCT00491595 -
Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women
|
Phase 1 | |
| Recruiting |
NCT03469063 -
Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients
|
N/A | |
| Not yet recruiting |
NCT04671589 -
Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.
|
Phase 4 | |
| Completed |
NCT03280368 -
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
|
||
| Withdrawn |
NCT01374061 -
Pre Hospital Evaluation of Video Laryngoscopy
|
Phase 4 | |
| Completed |
NCT03994302 -
Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)
|
||
| Completed |
NCT03392311 -
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
|
Phase 1/Phase 2 | |
| Terminated |
NCT00090844 -
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
|
Phase 2 | |
| Terminated |
NCT00213642 -
Tc-99m Renography and Cisplatin-induced Nephrotoxicity
|
N/A | |
| Recruiting |
NCT05022797 -
Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
|
Phase 2 |